–
Protara Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
0
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−47.5
FY22:
−67.1
FY23:
−43.6
FY24:
−49.2
FY25:
−64.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−45.4
FY22:
–
FY23:
−43.3
FY24:
−48.9
FY25:
−64.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−47.3
FY22:
–
FY23:
−40.4
FY24:
44.6
FY25:
57.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−47.3
FY22:
−66.0
FY23:
−40.4
FY24:
−44.6
FY25:
−57.4
All amounts in millions USD